These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6399890)
41. Bioavailability and elimination kinetics of the combination furosemide-retard/triamterene. Schuster O; Loew D; Knoell HE Eur J Drug Metab Pharmacokinet; 1985; 10(2):127-32. PubMed ID: 4043142 [TBL] [Abstract][Full Text] [Related]
42. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [TBL] [Abstract][Full Text] [Related]
43. Amiloride blocks the onset of ACTH-induced hypertension in the sheep. Reid AF; Coghlan JP; Whitworth JA; Scoggins BA Am J Hypertens; 1990 Oct; 3(10):775-81. PubMed ID: 2171563 [TBL] [Abstract][Full Text] [Related]
44. Comparative bio-availability of four formulations of furosemide. Meyer BH; Müller FO; Swart KJ; Luus HG; Werkman IM S Afr Med J; 1985 Oct; 68(9):645-7. PubMed ID: 3904040 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of furosemide after three different single oral doses. Waller ES; Massarella JW; Tomkiw MS; Smith RV; Doluisio JT Biopharm Drug Dispos; 1985; 6(2):109-17. PubMed ID: 4005391 [TBL] [Abstract][Full Text] [Related]
47. Absorption of high dose furosemide (frusemide) in congestive heart failure. Van Meyel JJ; Gerlag PG; Smits P; Russel FG; Tan Y; Van Ginneken CA; Gribnau FW Clin Pharmacokinet; 1992 Apr; 22(4):308-18. PubMed ID: 1606790 [TBL] [Abstract][Full Text] [Related]
48. Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers. De Gregori S; Cipollina L; De Silvestri A; Ventura M; Michelini R; Morosini M; Montagna M; Tinelli C; Regazzi M; Molinaro M; Imberti R Ther Drug Monit; 2017 Apr; 39(2):118-123. PubMed ID: 28196046 [TBL] [Abstract][Full Text] [Related]
49. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets. Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473 [TBL] [Abstract][Full Text] [Related]
50. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers. Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793 [TBL] [Abstract][Full Text] [Related]
51. Relative bioavailability and safety profile of gefitinib administered as a tablet or as a dispersion preparation via drink or nasogastric tube: results of a randomized, open-label, three-period crossover study in healthy volunteers. Cantarini MV; McFarquhar T; Smith RP; Bailey C; Marshall AL Clin Ther; 2004 Oct; 26(10):1630-6. PubMed ID: 15598479 [TBL] [Abstract][Full Text] [Related]
52. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects. Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030 [TBL] [Abstract][Full Text] [Related]
53. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers. Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers. Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292 [TBL] [Abstract][Full Text] [Related]
55. An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure. Latta D; Finnamore VP; Dalton K; Allman S J Int Med Res; 1990; 18 Suppl 2():10B-16B. PubMed ID: 2193839 [TBL] [Abstract][Full Text] [Related]
56. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers. Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579 [TBL] [Abstract][Full Text] [Related]
57. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR; Shah J Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [TBL] [Abstract][Full Text] [Related]
58. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers. Burkhardt O; Stass H; Thuss U; Borner K; Welte T Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283 [TBL] [Abstract][Full Text] [Related]
59. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. Allman S; Norris RJ J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840 [TBL] [Abstract][Full Text] [Related]
60. Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers. Ogata H; Zugarni S; Ejima A; Kawatsu Y Eur J Clin Pharmacol; 1983; 24(6):791-6. PubMed ID: 6688397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]